LULU Research Update β€” July 17, 2026

Updated Thesis

Lululemon Athletica is a premium athletic-apparel retailer whose technical-product innovation, powerful brand, direct-to-consumer retail and e-commerce model, and community-led marketing have historically supported high returns, including a 31.3% ROE, 55.7% gross margin, 18.2% operating margin, and 13.0% net margin. The investment case is now a turnaround rather than a clean compounding story: in the most recent quarter, revenue grew 4.3% year over year while earnings declined 38.0%, as Americas revenue fell 3%, comparable sales fell 5%, and Q1 gross margin contracted 410 basis points to 54.2%. At $116.33, the shares trade at 1.18x sales, 9.42x trailing earnings, 10.32x free cash flow, and 5.31x EV/EBITDA, which appears inexpensive versus the company’s historical quality and implies substantial skepticism about a durable U.S.

The investment grade as of this refresh is B- β€” solid business quality. Medium-tier business, attractive-tier valuation.

Grade Change

In this research cycle, the investment grade for Lululemon Athletica Inc. moved from B to B-. Medium-tier business, attractive-tier valuation.

Key Metrics at a Glance

Current price: $116.33

These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.

Our 12–18 Month Outlook

Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Lululemon Athletica Inc. remains in our covered universe with a solid-quality assessment. We update research when material data changes β€” earnings revisions, management shifts, or regime changes in valuation β€” not on every price fluctuation.

Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone β€” not whether to react to short-term price moves.

[View full LULU research β†’](/stocks/LULU)